Preventing and Treating Tobacco and Nicotine Use in Pediatrics
A Clinical Support Chart
Harold Farber & Matthew Bars
Preventing and Treating Tobacco and Nicotine Use in Pediatrics
A Clinical Support Chart
Harold Farber & Matthew Bars
Ringband
|
Engels
€ 71,50
- Vanaf €15,- geen verzendkosten.
- 30 dagen ruiltermijn voor fysieke producten
Omschrijving
This convenient reference provides clinicians with point-of-care guidance to help their patients stop using tobacco- and nicotine-containing products, as well as the latest clinical data to encourage them to never start.
Harold J. Farber, MD, MSPH, FAAP is a Professor of Pediatrics, Pulmonary Division at Baylor College of Medicine and Pediatric Pulmonologist at Texas Children's Hospital. His interests and accomplishments have focused on asthma, muscular dystrophies, tobacco dependence, and tobacco control. Dr. Farber has served as lead or co-author for close to 100 articles in the peer reviewed scientific literature. He has authored chapters on asthma education and on tobacco dependence for allergy and for pulmonary textbooks. Dr. Farber has served as co-principal investigator for the Lowering Environmental Tobacco Smoke Exposure: LETS Manage Asthma study. He served as founding executive committee member and policy chair for the American Academy of Pediatrics Section on Tobacco Control (now the Section on Nicotine and Tobacco Prevention and Treatment) and as chair of the American Thoracic Society Tobacco Action Committee. He served as co-author for the American College of Chest Physicians Tobacco Dependence Toolkit and as co-chair for the American Thoracic Society Clinical Practice Guideline, Initiating Pharmacologic Treatment in Tobacco Dependent Adults. Dr. Farber is a frequent speaker on tobacco control and tobacco dependence issues. He is interested in helping to ensure that tobacco dependence prevention and treatment is incorporated as a routine part of pediatric care. Outside of medicine, Dr. Farber’s interests include music, travel, and photography. His current musical interests include jazz and opera.
Matthew “Matt” Bars is a master's-level psychologist and has been engaged in the treatment, management, and administration of nicotine addiction services for many years. Matt was the Clinical Director of the IQuit Smoking Program at RWJ Barnabas Health-Jersey City Medical Center, Jersey City, New Jersey, and was appointed to their medical staff in 2011. He is also the co-developer and Clinical Director of the Tobacco Treatment Program of the New York City Fire Department (FDNY). The FDNY Tobacco Treatment Program enjoys a biochemically confirmed quit rate of ~70% at 10 year follow-up. Matt is also a former President of the Association for the Treatment of Tobacco Use and Dependence (ATTUD). ATTUD is a non-profit organization of providers dedicated to the promotion of and increased access to evidence-based tobacco treatment for the tobacco user. Since December 2006, he has been retained by the American College of Chest Physicians as a principal author for their Tobacco Treatment Toolkit, a training and consultation document and online resource for pulmonologists and other clinicians worldwide. In addition, he helps physicians, hospitals, and medical centers establish sustainable and clinically successful tobacco treatment programs. In March 2013, Matt was appointed to the faculty of St. George’s School of Medicine, Department of Psychiatry and he also serves on the editorial boards of the Journal of Smoking Cessation and the Journal of Medical Internet Research. Matt is the creator, founder and Chief Quitting Officer of IntelliQuit.org and CustomQuit.com, the world's first point-of-care, cloud-based biochemical nicotine monitor for health care professionals and tobacco and nicotine dependent patients.
Harold J. Farber, MD, MSPH, FAAP is a Professor of Pediatrics, Pulmonary Division at Baylor College of Medicine and Pediatric Pulmonologist at Texas Children's Hospital. His interests and accomplishments have focused on asthma, muscular dystrophies, tobacco dependence, and tobacco control. Dr. Farber has served as lead or co-author for close to 100 articles in the peer reviewed scientific literature. He has authored chapters on asthma education and on tobacco dependence for allergy and for pulmonary textbooks. Dr. Farber has served as co-principal investigator for the Lowering Environmental Tobacco Smoke Exposure: LETS Manage Asthma study. He served as founding executive committee member and policy chair for the American Academy of Pediatrics Section on Tobacco Control (now the Section on Nicotine and Tobacco Prevention and Treatment) and as chair of the American Thoracic Society Tobacco Action Committee. He served as co-author for the American College of Chest Physicians Tobacco Dependence Toolkit and as co-chair for the American Thoracic Society Clinical Practice Guideline, Initiating Pharmacologic Treatment in Tobacco Dependent Adults. Dr. Farber is a frequent speaker on tobacco control and tobacco dependence issues. He is interested in helping to ensure that tobacco dependence prevention and treatment is incorporated as a routine part of pediatric care. Outside of medicine, Dr. Farber’s interests include music, travel, and photography. His current musical interests include jazz and opera.
Matthew “Matt” Bars is a master's-level psychologist and has been engaged in the treatment, management, and administration of nicotine addiction services for many years. Matt was the Clinical Director of the IQuit Smoking Program at RWJ Barnabas Health-Jersey City Medical Center, Jersey City, New Jersey, and was appointed to their medical staff in 2011. He is also the co-developer and Clinical Director of the Tobacco Treatment Program of the New York City Fire Department (FDNY). The FDNY Tobacco Treatment Program enjoys a biochemically confirmed quit rate of ~70% at 10 year follow-up. Matt is also a former President of the Association for the Treatment of Tobacco Use and Dependence (ATTUD). ATTUD is a non-profit organization of providers dedicated to the promotion of and increased access to evidence-based tobacco treatment for the tobacco user. Since December 2006, he has been retained by the American College of Chest Physicians as a principal author for their Tobacco Treatment Toolkit, a training and consultation document and online resource for pulmonologists and other clinicians worldwide. In addition, he helps physicians, hospitals, and medical centers establish sustainable and clinically successful tobacco treatment programs. In March 2013, Matt was appointed to the faculty of St. George’s School of Medicine, Department of Psychiatry and he also serves on the editorial boards of the Journal of Smoking Cessation and the Journal of Medical Internet Research. Matt is the creator, founder and Chief Quitting Officer of IntelliQuit.org and CustomQuit.com, the world's first point-of-care, cloud-based biochemical nicotine monitor for health care professionals and tobacco and nicotine dependent patients.